Published in Blood Weekly, March 4th, 2004
NK cells "mediate bone marrow allograft rejection," scientists in Japan explained. "However, the molecular mechanisms underlying such a rejection remain elusive."
"In previous analyses, it has been shown that NK cells recognize allogeneic target cells through Ly-49s and CD94/NKG2 heterodimers," noted J. Koike and colleagues at Chiba University. In their study, they discovered a "novel murine NK receptor, NKG2I, belonging to the NKG2 family."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.